ADMA Biologics, Inc.ADMANASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank64
3Y CAGR+19.6%
5Y CAGR+16.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+19.6%/yr
vs -5.9%/yr prior
5Y CAGR
+16.4%/yr
Recent acceleration
Acceleration
+25.5pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.52 | -9.1% |
| 2024 | 9.37 | +139.1% |
| 2023 | 3.92 | -21.3% |
| 2022 | 4.98 | +104.9% |
| 2021 | 2.43 | -38.9% |
| 2020 | 3.98 | -46.3% |
| 2019 | 7.41 | +16.5% |
| 2018 | 6.36 | +96.9% |
| 2017 | 3.23 | -44.7% |
| 2016 | 5.84 | - |